UBS Maintains Sell Rating for Unilever with £40.00 Target Price
ByAinvest
Sunday, Apr 27, 2025 6:09 pm ET1min read
UL--
Key drivers for the company's performance were the Home Care segment, which contributed ₹229.6 billion, accounting for 36% of total revenue. The company's earnings per share (EPS) also surpassed analyst estimates, increasing from ₹43.74 in FY 2024 to ₹45.32 [1].
Looking ahead, Hindustan Unilever has forecasted an average revenue growth of 6.4% per annum over the next three years, compared to the industry average of 7.4% for the Personal Products sector in India. Despite these positive projections, the company's shares have seen a decline of 1.8% from a week ago [1].
Analysts have varying opinions on the stock. UBS maintains a Sell rating with a £40.00 price target, while the Moderate Buy consensus rating has an average price target of £4,856.11, representing a 2.32% upside from current levels. Analyst Guillaume Delmas has a 2-star rating and a 44.55% success rate [2].
References:
[1] https://simplywall.st/stocks/in/household/nse-hindunilvr/hindustan-unilever-shares/news/hindustan-unilever-full-year-2025-earnings-beats-expectation
[2] https://simplywall.st/stocks/in/household/nse-hindunilvr/hindustan-unilever-shares/news/hindustan-unilever-full-year-2025-earnings-beats-expectation
VVR--
UBS maintains a Sell rating on Unilever (ULVR) with a £40.00 price target, despite the company's recent earnings release of £29.64 billion in revenue and £2.04 billion in net profit for Q4. Analyst Guillaume Delmas has a 2-star rating and a 44.55% success rate. The Moderate Buy analyst consensus rating has a £4,856.11 average price target, a 2.32% upside from current levels.
Hindustan Unilever (HINDUNILVR) recently reported its full-year 2025 earnings, which exceeded analyst expectations. The company's revenue for the period was ₹631.2 billion, a 2.0% increase from the previous fiscal year (FY 2024). Net income reached ₹106.5 billion, marking a 3.6% growth compared to FY 2024. The profit margin remained at 17%, in line with the previous year [1].Key drivers for the company's performance were the Home Care segment, which contributed ₹229.6 billion, accounting for 36% of total revenue. The company's earnings per share (EPS) also surpassed analyst estimates, increasing from ₹43.74 in FY 2024 to ₹45.32 [1].
Looking ahead, Hindustan Unilever has forecasted an average revenue growth of 6.4% per annum over the next three years, compared to the industry average of 7.4% for the Personal Products sector in India. Despite these positive projections, the company's shares have seen a decline of 1.8% from a week ago [1].
Analysts have varying opinions on the stock. UBS maintains a Sell rating with a £40.00 price target, while the Moderate Buy consensus rating has an average price target of £4,856.11, representing a 2.32% upside from current levels. Analyst Guillaume Delmas has a 2-star rating and a 44.55% success rate [2].
References:
[1] https://simplywall.st/stocks/in/household/nse-hindunilvr/hindustan-unilever-shares/news/hindustan-unilever-full-year-2025-earnings-beats-expectation
[2] https://simplywall.st/stocks/in/household/nse-hindunilvr/hindustan-unilever-shares/news/hindustan-unilever-full-year-2025-earnings-beats-expectation

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet